专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010081418A8 APPLICATION OF AQUEOUS SOLUTION OF MAGNESIUM BICARBONATE AND/OR CALCIUM BICARBONATE IN THE PROCESS OF EXTRACTION SEPARATION AND PURIFICATION OF METALS 审中-公开
标题翻译：二氧化碳和/或二碳酸钙的水溶液在金属萃取分离和纯化过程中的应用
公开(公告)号：WO2010081418A8
公开(公告)日：2011-01-13
申请号：PCT/CN2010070182
申请日：2010-01-14
申请人： GEN RES INST NONFERROUS METALS , GRIREM ADVANCED MATERIAL CO LTD , HUANG XIAOWEI , LONG ZHIQI , PENG XINLIN , LI HONGWEI , YANG GUILIN , CUI DALI , WANG CHUNMEI , ZHAO NA , WANG LIANGSHI , YU YING
发明人： HUANG XIAOWEI , LONG ZHIQI , PENG XINLIN , LI HONGWEI , YANG GUILIN , CUI DALI , WANG CHUNMEI , ZHAO NA , WANG LIANGSHI , YU YING
IPC分类号： C22B3/26 , C22B3/32 , C22B3/40
CPC分类号： C22B59/00 , C22B3/0005 , C22B3/0043 , C22B3/0067 , C22B3/0068 , Y02P10/234
摘要： The application of aqueous solution of magnesium bicarbonate and/or calcium bicarbonate in the process of extraction separation and purification of metals is disclosed, wherein the aqueous solution of magnesium bicarbonate and/or calcium bicarbonate is used as an acidity balancing agent, in order to adjust the balancing pH value of the extraction separation process which uses an acidic organic extractant, improve the extraction capacity of organic phase, and increase the concentration of metal ions in the loaded organic phase.
摘要翻译：公开了在金属萃取分离和纯化过程中应用碳酸氢镁和/或碳酸氢钙的水溶液，其中将碳酸氢镁和/或碳酸氢钙的水溶液用作酸度平衡剂，以便调节使用酸性有机萃取剂的提取分离过程的平衡pH值，提高有机相的萃取能力，提高负载有机相中金属离子的浓度。

2. 发明申请

WO2009034345A1 METHOD AND SYSTEM FOR MONITORING AND CONTROLLING A MULTI-VARIABLE PROCESS THROUGHOUT A PLURALITY OF DISTINCT PHASES OF THE PROCESS 审中-公开
标题翻译：用于监测和控制多变量过程的方法和系统，通过该过程的大量不同阶段
公开(公告)号：WO2009034345A1
公开(公告)日：2009-03-19
申请号：PCT/GB2008/003105
申请日：2008-09-15
申请人： CURVACEOUS SOFTWARE LIMITED , BROOKS, Robin, William , WILSON, John, Gavin , ZHAO, Na
发明人： BROOKS, Robin, William , WILSON, John, Gavin , ZHAO, Na
IPC分类号： G05B19/418 , G05B23/02
CPC分类号： G05B23/024 , G05B19/41875 , G05B2219/11 , G05B2219/1112 , G05B2219/35507 , Y02P90/22
摘要： Control of a multi-variable process throughout a plurality of successive, distinct operational phases of the process involves accumulation of sets of values of the process and quality variables (a-j) from previous multiple operations of the process through all its phases, as respective datasets of a historical record. Each dataset includes an identifier (p) of the phase to which it relates. The current values of the applicable process variables (Qa-Qh) during each phase and the phase identifier (p) are indicated on respective axes (Xp, Xa-Xh) of a multi-dimensional display in relation to an operational envelope which defines bounds (UL, LL) for the values of the individual process and quality variables {a-j) relevant to that phase and which is derived from the datasets of the historical record identified with that phase. Changes in the current process variables (Qa-Qh) result in changes of the bounds (UL, LL), and alarm is given when a current value departs from within them. Correction of an alarm condition is made manually or automatically in accordance with calculation of required change of value of one or more manipulatable process variables (a-c).
摘要翻译：在过程的多个连续的，不同的操作阶段中对多变量过程的控制涉及从过程的所有阶段的先前多次操作中累积过程值和质量变量（aj）的集合，作为相应的数据集一个历史记录。每个数据集包括与其相关的阶段的标识符（p）。相对于定义边界的操作包络，在多维显示器的各个轴（Xp，Xa-Xh）上指示每个阶段期间适用的过程变量（Qa-Qh）和相位标识符（p）的当前值（UL，LL）用于与该阶段相关的单个过程和质量变量{aj）的值，并且是从与该阶段确定的历史记录的数据集中得出的。当前过程变量（Qa-Qh）的变化导致边界（UL，LL）的变化，并且当当前值从其中偏离时给出报警。根据计算一个或多个可操作过程变量（a-c）的所需值的变化，手动或自动地进行报警条件的更正。

3. 发明申请

WO2008118331A2 TABLET FORMULATIONS CONTAINING 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROM 审中-公开
标题翻译：含有8 - [{1-（3,5-双 - （三氟甲基）苯基） - 乙基} - 甲基] -8-苯基-1,7-二氮杂螺[4.5]癸烷-2-酮的片剂配方和片剂制作它
公开(公告)号：WO2008118331A2
公开(公告)日：2008-10-02
申请号：PCT/US2008/003653
申请日：2008-03-20
申请人： SCHERING CORPORATION , QIU, Zhihui , CHO, Wing-kee, Philip , ZHAO, Na , WONG, Victor, Ming-she
发明人： QIU, Zhihui , CHO, Wing-kee, Philip , ZHAO, Na , WONG, Victor, Ming-she
IPC分类号： A61K9/20
CPC分类号： A61K31/435 , A61K9/1652 , A61K9/1682 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/2095 , A61K9/28 , A61K31/438
摘要： Pharmaceutical formulations containing a salt of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, which are suitable for forming into a tablet dosage form, as well as tablet dosage forms are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.
摘要翻译：含有（5S，8S）-8 - [{（1R）-1-（3,5-双 - （三氟甲基）苯基） - 乙氧基} - 甲基] -8-苯基-1,7-二氮杂螺公开了由式I代表的适合形成片剂剂型的[4.5]癸-2-酮以及片剂剂型。还公开了利用这种剂型的治疗方法。

4. 发明申请

WO2021110733A1 A COSMETIC COMPOSITION AND THE USE THEREOF AND A METHOD FOR IMPROVING SENSORY CHARACTERISTICS 审中-公开
公开(公告)号：WO2021110733A1
公开(公告)日：2021-06-10
申请号：PCT/EP2020/084244
申请日：2020-12-02
申请人： BASF SE , ZHAO, Na
发明人： LEE, Dong, Ryeol , HU, Ling, Ting , WANG, Qiu, Jing , WANG, Yi, Yao , XU, Yu, Ting
IPC分类号： A61Q5/00 , A61Q17/04 , A61Q11/00 , A61Q17/02 , A61Q19/00 , A61K8/04 , A61K8/06 , A61K8/81 , A61K8/86 , A61K8/39 , A61K8/37 , A61K8/90
摘要： The present invention provides a cosmetic composition, comprising (a) 0.01wt%-2.0wt% of at least one gel-forming (meth)acrylic polymer, (b) 0.01wt%-1.0wt%, excluding 1.0wt%, of at least one non-ionic emulsifier, which is selected from the group consisting of polyethylene glycol diester of fatty acids, polypropylene glycol diester of fatty acids and poly(ethylene-co-propylene glycol) diesters of fatty acids, (c) 0.01wt%-1.0wt%, of at least one solubilizer having an HLB value in the range of 12-20, and (d) water, each based on the total weight of the cosmetic composition, wherein said composition is in gel or oil in water emulsion form, preferably in gel form. The cosmetic composition of the invention is in the form, refreshing, non-greasy and easier to distribute.

5. 发明申请

WO2008118331A3 TABLET FORMULATIONS CONTAINING 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL)PHENYL)-ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE SALTS AND TABLETS MADE THEREFROM 审中-公开
标题翻译：含有8 - [{1-（3,5-双 - （三氟甲基）苯基） - 乙基} - 甲基] -8-苯基-1,7-二氮杂螺[4.5]癸烷-2-酮的片剂配方和片剂制作它
公开(公告)号：WO2008118331A3
公开(公告)日：2009-04-23
申请号：PCT/US2008003653
申请日：2008-03-20
申请人： SCHERING CORP , QIU ZHIHUI , CHO WING-KEE PHILIP , ZHAO NA , WONG VICTOR MING-SHE
发明人： QIU ZHIHUI , CHO WING-KEE PHILIP , ZHAO NA , WONG VICTOR MING-SHE
IPC分类号： A61K9/20
CPC分类号： A61K31/435 , A61K9/1652 , A61K9/1682 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/2095 , A61K9/28 , A61K31/438
摘要： Pharmaceutical formulations containing a salt of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, which are suitable for forming into a tablet dosage form, as well as tablet dosage forms are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.
摘要翻译：含有（5S，8S）-8 - [{（1R）-1-（3,5-双 - （三氟甲基）苯基） - 乙氧基} - 甲基] -8-苯基-1,7-二氮杂螺公开了由式I代表的适合形成片剂剂型的[4.5]癸-2-酮以及片剂剂型。还公开了利用这种剂型的治疗方法。

6. 发明申请

WO2005049058A8 RADIX SALVIAE MILTIORRHIZAE, EXTRACT AND COMPOSITION THEREOF FOR THE TREATMENT OF THE ASPIRIN RESISTANCE DISEASES 审中-公开
标题翻译： RADIX SALVIAE MILTIORRHIZAE，其治疗抗甲状腺疾病的提取物和组合物
公开(公告)号：WO2005049058A8
公开(公告)日：2005-08-11
申请号：PCT/CN2004000989
申请日：2004-08-26
申请人： TIANJIN TASLY PHARMACEUTICAL , YAN XIJUN , WU NAIFENG , YE ZHENGLIANG , LI XU , GUO ZHIXIN , ZHENG JUN , ZHAO NA
发明人： YAN XIJUN , WU NAIFENG , YE ZHENGLIANG , LI XU , GUO ZHIXIN , ZHENG JUN , ZHAO NA
IPC分类号： A61K36/00 , A61K36/185 , A61K36/258 , A61K36/537 , A61K45/06 , A61P9/00 , A61K35/78
CPC分类号： A61K36/537 , A61K36/185 , A61K36/258 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the uses of Radix Salviae Miltiorrhizae, extract and composition thereof in the treatment of the aspirin resistance diseases, especially in the treatment of the aspirin resistance angiocardiopathy with drop pills of Radix Salviae miltiorrhizae.
摘要翻译：本发明涉及丹参，其提取物及其组合物在治疗阿司匹林耐药性疾病中的应用，特别是在使用丹参滴丸治疗阿司匹林抵抗性心血管病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式